Board of Advisors

The Guarini Advisory Board was established in 2019 and meets at least twice a year to discuss Guarini School strategy, programs, policies, and resources. Advisors serve three-year terms, limited to three consecutive terms. 

• Kristen M. Garner Amanti, PhD, GR'10 MED'10
• Allison S. Bailey '87 (Chair)
• Niranjan Bose, PhD GR'04 MED'04
• Benjamin C. Burke, PhD, GR'06
• Ting Cai, GR'96 P'25 P'27
• Arijit Chakravarty, PhD, GR '03 MED '03
• Ronald R. "Ron" Chance, PhD, GR '74
• Shinichiro "Shin" Fuse, PhD, GR '08 MED '08 
• Odette Harris '91, MD, MPH, Board of Trustees Representative
• Michelle "Mikki" Hebl, PhD, GR'97
• David A. Silbersweig, MD, '82
• Julie N. Skinner Manegold, PhD, GR'15
• Joel Stettenheim, PhD, GR'12
• Henry N. Tisdale, PhD, GR'75 GR'78
• Ben Vinson III, PhD, '92
• Yanjun "Keene" Wei, PhD GR'04
• Marco A. Zarbin, MD, PhD, '78 P'28 P'28

kristen-amanti.jpg

 Kristen is a partner at Health Advances, a strategy consulting firm that serves clients across the life sciences industry. She is a leader of the precision medicine practice and her work largely focuses on the development of commercialization strategies and business development opportunity assessment in the areas of oncology, women's and reproductive health, and rare disease. She established and leads the pro bono consulting initiative at Health Advances, working to support mission driven organizations achieve their goals in advancing healthcare access and quality. At Dartmouth, she is an academic advisory member for the Dartmouth Biotech Club. Kristen holds a BS and MS in biology from University of Vermont and a PhD in pharmacology from Dartmouth College.

baileyallison87_nom_041957.jpg

Allison is vice chair at Boston Consulting Group and a global leader of the firm's people and organization practice. The Boston Consulting Group strives to empower organizations to grow, build sustainable competitive advantage, and drive positive societal impact. She has worked extensively with clients in the media, technology, consumer goods, health care, education, and financial services fields on issues related to strategy, growth, organization, large-scale transformation, operational improvement, turnaround, mergers and acquisitions, and post-merger integration. Allison advises company leaders on setting overall strategic direction, managing through transition, building effective leadership teams, and driving value. Allison is a former Dartmouth Admissions alumni interviewer (1988–2002).

bb.png

Dr. Burke is CEO and co-founder of Gradient Geothermal, Inc., a Denver-based geothermal technology company. Prior to that, he worked as a geologist and geoscience manager in the oil and gas industry in both Houston and Denver for Exxon Mobil, Noble Energy, Fidelity Exploration & Production, and Fifth Creek Energy, a private-equity based startup. He began his career in subsurface energy and resources as an environmental consultant for Woodard & Curran, Inc. in Connecticut. He holds an AB magna cum laude from Bowdoin College in geology and russian Language, a MBA from Texas A&M University, and a PhD in earth sciences from Dartmouth College.

boa-ting-cai.jpg

Ting is Chief Data Officer & Group Senior Managing Executive Officer of Technology Services at Rakuten Institute of Technology. Prior to this role, he was employed with Microsoft for over 15 years. Currently, he is the partner director of product and technology and director of Bing News, Microsoft's news aggregator powered by artificial intelligence that is part of the Bing search engine. Ting is responsible for working on speech and search products and technology including news, multimedia, relevance, platform, user experience, and mobile app, as well as the global Bing news product, engineering, and publisher engagement teams. He is a frequent speaker at Big Data and AI for Media conferences around the world and served as a juror for the AI and the News Open Challenge (2019).

boa-arjit-chakravarty.jpg

Arijit is the chief executive officer for Fractal Therapeutics, a model-based drug discovery and development company, focused on building a pipeline of novel assets in oncology, infectious disease, and rare diseases. Prior to that, he worked for Takeda Pharmaceuticals in roles of increasing responsibility spanning a diverse range of functions within the research and development organization. Over his career as a scientist, Arijit contributed to over 50 drug development programs, presented at over 100 conferences and seminars, and co-authored 31 peer-reviewed papers and book chapters. Arijit served as adjunct faculty in the Department of Computational Biology at Carnegie Mellon University (2008–2017). He serves as the chair of Board of Directors for Perceptx (2018– ).

boa-shin-fuse.jpg

Shinichiro (Shin) is a partner and managing director at TPG. Shin is an investment committee member of the UBS Oncology Impact Fund (OIF), an oncology-only crossover fund (both private and public equities) managed by MPM, and supports MPM's relationship with Astellas. Shin serves on the boards of Triplet Therapeutics, Orna Therapeutics and iOmx Therapeutics, and is a board observer for CODA Biotherapeutics and was previously a board observer for Repare Therapeutics (NASDAQ: RPTX). He previously served operational roles at portfolio companies as the interim CEO of Orna Therapeutics and interim SVP of Business Development at ElevateBio, where he led several deals including Allovir (NASDAQ: ALVR) and HighPass Bio.  Prior to joining MPM, he was Director of Business Development at bluebird bio, where he was instrumental in executing and managing key industry and academic partnerships in the fields of cell and gene therapy, cancer immunotherapy and genome editing, including partnerships with Five Prime Therapeutics, National Cancer Institute and the acquisition of Pregenen. Previously, he was at Campbell Alliance (Syneos Health) as a life science strategy consultant, and at PureTech Ventures, where he was a member of the founding team of Vedanta Biosciences. He also serves as a columnist for Nikkei Biotech, the leading biotech journal in Japan. Shin received his PhD in microbiology and immunology from Dartmouth College, an MS in biomedical science from the University of Tokyo, and a BEng in applied chemistry from Keio University in Japan.

unknown-1.jpeg

 Mikki is the Martha and Henry Malcolm Lovett Chair of Psychology at Rice University and Professor of Organizational Behavior at the Jones Graduate School of Business. Her research focuses on diversity and discrimination-related issues. In 2014, Mikki received the Sage Award for Scholarly Contributions from the Academy of Management for her lifetime research on gender and diversity in organizations. She is an author on over 200 publications and has earned 21 teaching awards, including the Robert Foster Cherry Award, one of the nation's most prestigious teaching awards. Mikki has also received research grants from the National Science Foundation and the National Institutes of Health. She holds a BA in psychology from Smith College and a PhD in psychology from Dartmouth.

silbersweig.jpg

David, a neurologist and psychiatrist, is one of the pioneers of functional neuroimaging research in psychiatry. The aim of his work in systems-level neuropathophysiology is to help provide a foundation for the development of novel, targeted, and biologically based diagnostic and therapeutic strategies to aid those suffering with mental illness. David is the chairman of the Department of Psychiatry at the Brigham and Women's Hospital and co-director of the Brigham's Institute for the Neurosciences. He also is Stanley Cobb Professor of Psychiatry at Harvard Medical School. He was an Academic Dean at Harvard Medical School for seven years.  David has played a notable role in shaping the rapidly developing field of neuropsychiatry through his clinical and scientific work, innovative educational activities, invited presentations in the United States and abroad, and his work with scientific journals and organizations. He is a Fellow of the American Neuropsychiatric Association, Consulting Editor of the Journal of Neuropsychiatry and Clinical Neurosciences, and editor of a major textbook of Neuropsychiatry and Behavioral Neurology.  He has significant involvement and leadership roles in national and international research consortia. David was the founding vice chairman of the governing board of the National Network of Depression Centers and a board member for the Brain Science Foundation.  He is on the board of the Spaulding Rehabilitation Network.  His Dartmouth service includes Admissions alumni interviewer (2015–2021); Alumni Council (AC) Nomination and Alumni Trustee Search Committee, member (2017–2020); AC Executive Committee, member (2017–2018); Alumni Council, member (2015–2018); AC Academic Affairs Committee, chair (2017–2018) member (2015–2016), vice chair (2016–2017); and Alumni Advisory Jewish Life, member (1984–1989). David was a Montgomery Fellow at Dartmouth in the Fall of 2022.

boa-julie-skinner.jpg

Julie is an astronomer specializing in the observation and characterization of the smallest stars and their stellar and planetary companions.  Most recently, she was visiting faculty at Smith College.  Prior to that, she was a postdoctoral scholar at Boston University's Institute for Astrophysical Research, where she founded the Women as Leaders in Astronomy program and was the Assistant Director for the NSF-funded astronomy REU program in addition to her scholarly pursuits.  While at Dartmouth, Julie was given the Physics & Astronomy Chair's teaching award, was an NSF GK-12 Fellow, and was the Graduate Fellow for Professional Development Programs.  In this capacity, she developed a plan for school-wide TA training and facilitated workshops for graduate students and postdoctoral scholars on best practices in teaching and learning through the Dartmouth Center for the Advancement of Learning. Julie holds a bachelor's degree in astrophysics from the University of Oklahoma and a PhD in physics and astronomy from Dartmouth College.

joel.jpg

Joel Stettenheim is President of Norwich Solar, Inc. Dr. Stettenheim's broad technical skills include materials and device fabrication and characterization, control systems development, design and implementation of mechanical and electrical simulations, data analysis, mechanical design and machining, and extensive measurement work that includes design and fabrication of low-noise electronics and device-control and data-collection software. His research credentials include numerous peer-reviewed publications and public talks including lead authorship in Nature. Joel's legal and business experience includes counseling clients from start-ups to Fortune 500 companies on a broad range of patent, trademark, regulatory, transactional, and licensing issues. Joel is PI on over $2.4M in grants from the US Department of Energy for the novel parabolic trough concentrating solar power and other technology being developed by NST. He practiced intellectual property and corporate law at Testa, Hurwitz & Thibeault and holds a JD from Stanford Law School, a PhD in physics from Dartmouth College, and a BA from Haverford College.

boa-ben-vinson.jpg

Dr. Vinson was the 18th President of Howard University. Prior to this, he served as the provost and executive vice president at Case Western Reserve University in Cleveland, OH where he was responsible for all facets of the academic programs and research of the University. He is an accomplished historian of Latin America and served on the faculties of Barnard College and Penn State before joining Johns Hopkins as a professor of history and founding director of its Center for Africana Studies. Ben went on to serve as a vice dean for centers, interdisciplinary studies, and graduate education before becoming dean of George Washington University's Columbian College of Arts and Sciences. Under his leadership, Columbian College increased interdisciplinary initiatives, enhanced diversity, and substantially grew research efforts. Ben led the integration of the Corcoran School of the Arts and Design into Columbian College, collaborated with the dean of engineering to open an interdisciplinary science and engineering building, and initiated graduate degree programs in data science and applied economics. He serves on The National Humanities Center Board of Trustees (2013– ), chair (2018—) and is a member of the American Historical Association. Ben has been awarded fellowships from the Fulbright Commission, National Humanities Center, Social Science Research Council, University of North Carolina at Chapel Hill, Ford Foundation, Rockefeller Foundation, and Mellon Foundation. At Dartmouth, he served as an Admissions alumni interviewer (2016–2017).

zarbin_7-18.jpg

Dr. Marco Zarbin is the Alfonse A. Cinotti, MD/Lions Eye Research Professor and Chair of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Chief of Ophthalmology at University Hospital, Newark, and co‑director of the Ocular Cell Transplantation Laboratory and the Center for Macular Degeneration Research. His clinical practice and research address medical and surgical diseases of the retina and vitreous, including age‑related macular degeneration, diabetic retinopathy, complex retinal detachment, and macular surgery. He has published hundreds of peer‑reviewed articles and chapters, coedited multiple books, was founding editor of Translational Vision Science & Technology, and sits on the editorial boards of Ophthalmology and Ophthalmology Retina. Dr. Zarbin is Vice Chair of the Scientific Advisory Board of the Foundation Fighting Blindness, served as the Department of Veterans Affairs representative to the NEI National Advisory Eye Council, co‑founded the biotech company NVasc, and received major honors including a Life Achievement Award from the American Academy of Ophthalmology, a Leadership Award from the Polish Academy of Ophthalmology, and a Distinguished Service Award from the Association for Research in Vision and Ophthalmology. He holds a BA in biochemistry from Dartmouth College and an MD and PhD (pharmacology) from Johns Hopkins University School of Medicine.